Contrave: FDA Decision, Chances for Approval

Contrave is a treatment for obesity that consists of bupropion combined with naltrexone. An FDA advisory panel voted 13-7 for its approval in December.  In the end of January, it is going for an official FDA decision. Based on a variety of factors, we would hedge...
Obesity Drugs 2010, Which Is the Best?

Obesity Drugs 2010, Which Is the Best?

Three weight-loss pills are going up for FDA approval this year, 2010 – Qnexa, lorcaserin, and Contrave.  Here we present the state of the field for weight-loss pills and analyze each treatment. Currently, there are not that many treatments for obesity right now in...